Technology and data have become central to every aspect of modern life, and new technologies such as continuous glucose monitoring (CGM) and connected insulin pens have the potential to be transformational to the general practice management of type 2 diabetes. This advanced course aims to educate GPs on the use of these technologies, exploring how the resulting valuable data and insights can allow you to provide more targeted, personalised and effective type 2 diabetes management for your patients.
Presented by leading experts A/Prof Gary Kilov AM and A/Prof Margaret McGill AM, this advanced course – described by one GP as ‘a total lightbulb moment’ – will take you on an illuminating journey into data-driven type 2 diabetes management, enabling you to practically engage with the technology and data that can change our patients’ lives.
On completion of this education activity participants will be able to:
- Understand the applications and roles of new technologies such as continuous glucose monitoring (CGM) and connected insulin pens in T2D management.
- Analyse the glucose data in an ambulatory glucose profile (AGP) report/Glucose Pattern Insights (GPI) report and recognise glucose variability and its possible causes.
- Select appropriate patients and apply information gained from new technologies towards optimising individualised T2D care.
- Engage in patient education to ensure patients' understanding and utilisation of new technologies.
Presenters
Clinical A/Prof Gary Kilov (University of Melbourne and University of Sydney) is a GP working in N. Tasmania and is affiliated with the Baker Heart and Diabetes institute. A founding member of the Royal Australian College of General Practitioners (RACGP) Diabetes specific interest group and the Primary Care Diabetes Society of Australia (PCDSA), he is a contributor to the RACGP Management of type 2 diabetes handbook (2012-2024, and a member of several NDSS (National Diabetes Supply Scheme) Expert Reference Groups. He is involved in undergraduate and postgraduate education both within Australia and internationally, and is widely published in peer reviewed journals on topics covering diabetes, obesity and respiratory medicine.
Associate Professor at University of Sydney Central Clinical School, Faculty of Medicine and Health and Associate Director of the Royal Prince Alfred Hospital Diabetes Centre. A/Prof McGill is a recognised global leader in the development of innovative clinical services for diabetes and medical and health professional education.
